DPDharmeshkumar Parmar

Dharmeshkumar Parmar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Dharmeshkumar Parmar has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Computational Mass Spectrometry Imaging in the Era of AI

    by Timothy J. Trinklein, Mithunjha Anandakumar, Hsi-Chun Chao, Marisa Asadian, Dharmeshkumar Parmar, Jonathan V. Sweedler, Fan Lam

    Mass spectrometry imaging (MSI) is a tool-of-choice for mapping and understanding the spatial organization of biomolecules, including small metabolites, lipids, peptides, and many others. As the MSI instrument and spatial biology inquiries evolve, researchers and practitioners are constrained by the inherent trade-offs in spatial resolution, chemical detail, and acquisition time. Here, we review how the rapidly growing interplay between MSI and machine learning/artificial intelligence (ML/AI)-powered computational approaches is addressing these issues. We begin by highlighting key steps in MSI experiments and summarizing major ML/AI paradigms in the context of MSI data, providing a foundation to review how ML/AI impact each step in the MSI workflow, starting with methods to accelerate data acquisition. We then discuss emerging applications of dimensionality reduction, segmentation, and various supervised/unsupervised learning approaches to extract useful chemical insights from high-dimensional MSI data. Approaches to leverage multimodal imaging to guide the acquisition process or provide a more informative integrated analysis are discussed. We conclude with a forward-looking discussion on the state of computation and MSI, spanning ML-enabled instrumentation, scaling measurements to 3D and large cohorts, and the integration of MSI with other spatial omic data.

  • Effect of Micro-Patterned Mucin on Quinolone and Rhamnolipid Profiles of Mucoid Pseudomonas aeruginosa under Antibiotic Stress

    by Jin Jia, Dharmeshkumar Parmar, Joanna F. Ellis, Tianyuan Cao, Allison R. Cutri, Joshua D. Shrout, Jonathan V. Sweedler, Paul W. Bohn

    Pseudomonas aeruginosa is commonly implicated in hospital acquired infections where its capacity to form biofilms on a variety of surfaces and the enhanced antibiotic resistance that results seriously limit treatment choices. Because surface attachment sensitizes P. aeruginosa to quorum sensing (QS) and induces virulence through both chemical and mechanical cues, we investigate the effect of surface properties through spatially-patterned mucin, combined with sub-inhibitory concentrations of tobramycin on QS and virulence factors in both mucoid and non-mucoid P. aeruginosa strains using multi-modal chemical imaging combining confocal Raman microscopy (CRM) and matrix-assisted laser desorption/ionization-mass spectrometry (MALDI-MS). Samples are comprised of surface-adherent static biofilms at a solid-water interface, supernatant liquid, and pellicle biofilms at an air-water interface at various time points. Although the presence of a sub-inhibitory concentration of tobramycin in the supernatant retards growth and development of static biofilms independent of strain and surface mucin patterning, we observe clear differences in the behavior of mucoid and non-mucoid strains. Quinolone signals in a non-mucoid strain are induced earlier and are influenced by mucin surface patterning to a degree not exhibited in the mucoid strain tested. Additionally, phenazine virulence factors, such as pyocyanin (PYO), are observed in the pellicle biofilms of both mucoid and non-mucoid strains, but are not detected in the static biofilms from either strain, highlighting the differences in stress response between pellicle and static biofilms. Differences between mucoid and nonmucoid strains are consistent with their strain-specific phenology, in which the mucoid strain develops highly protected biofilms.


  • Open Access

    Plausible diagnostic value of urinary isomeric dimethylarginine ratio for diabetic nephropathy

    by Dharmeshkumar Parmar, Nivedita Bhattacharya, Shanthini Kannan, Sangeetha Vadivel, Gautam Kumar Pandey, Avinash Ghanate, Nagarjuna Chary Ragi, Paramasivam Prabu, Thyparambil Aravindakshan Pramodkumar, Nagaraj Manickam, et al.

    Altered circulatory asymmetric and symmetric dimethylarginines have been independently reported in patients with end-stage renal failure suggesting their potential role as mediators and early biomarkers of nephropathy. These alterations can also be reflected in urine. Herein, we aimed to evaluate urinary asymmetric to symmetric dimethylarginine ratio (ASR) for early prediction of diabetic nephropathy (DN). In this cross-sectional study, individuals with impaired glucose tolerance (IGT), newly diagnosed diabetes (NDD), diabetic microalbuminuria (MIC), macroalbuminuria (MAC), and normal glucose tolerance (NGT) were recruited from Dr. Mohans’ Diabetes Specialties centre, India. Urinary ASR was measured using a validated high-throughput MALDI-MS/MS method. Significantly lower ASR was observed in MIC (0.909) and MAC (0.741) in comparison to the NGT and NDD groups. On regression models, ASR was associated with MIC [OR: 0.256; 95% CI: 0.158–0.491] and MAC [OR 0.146; 95% CI: 0.071–0.292] controlled for all the available confounding factors. ROC analysis revealed ASR cut-point of 0.95 had C-statistic of 0.691 (95% CI: 0.627-0.755) to discriminate MIC from NDD with 72% sensitivity. Whereas, an ASR cut-point of 0.82 had C-statistic of 0.846 (95% CI: 0.800 - 0.893) had 91% sensitivity for identifying MAC. Our results suggest ASR as a potential early diagnostic biomarker for DN among the Asian Indians.


  • Open Access

    MQ: Tool for HR-AM Based Quantitative Analysis for Direct MS Workflow

    by Avinash Ghanate, Dharmesh Parmar, Nivedita Bhattacharya, Ijaz Inamdar, Gayatri Phadke, Venkateswarlu Panchagnula

    There is an increased interest in using high-resolution mass spectrometry (HRMS) in the full scan mode (FS) for simultaneous qualitative and quantitative analysis with accurate mass based extracted ion chromatograms (HRMS-AM) for metabolomic profiling workflows. Herein, the capabilities and features of ‘MQ’, a common platform developed to support quantitative analysis from HRMS data are described. Module for qualitative annotation utilizes peak features that include mass accuracy, peak width, and relative abundance of isotopic distribution that offer reliable metabolic confirmation. Additionally, MQ provides multivariate clustering with Principal Component Analysis and a module for high-throughput database query based on user configurable annotated metabolite lists. MQ is capable of handling system-agnostic data formats from both direct HRMS and LC-HRMS analysis. Data processed using MQ for LC-HRMS-AM quantitation of amino acids benchmarked using a commercial tool is presented that validates the quantitative capabilities of the algorithm developed. Datasets representative of three different HRMS-AM based analysis scenarios have been showcased to demonstrate the utility of MQ. Availability and implementation Freely available on web at, http://www.ldims.com/services/software. MQ is implemented in Java and supported on Linux and Microsoft Windows system having Java runtime environment (JRE) pre-installed.

  • Superfluous glutamine synthetase activity in Chinese Hamster Ovary cells selected under glutamine limitation is growth limiting in glutamine‐replete conditions and can be inhibited by serine

    by Vishwanathgouda Maralingannavar, Dharmeshkumar Parmar, Venkateswarlu Panchagnula, Mugdha Gadgil

    Passaging and expansion of animal cells in lean maintenance medium could result in periods of limitation of some nutrients. Over time, such stresses could possibly result in selection of cells with metabolic changes and contribute to heterogeneity. Here, we investigate whether selection of Chinese Hamster Ovary (CHO) cells under glutamine limitation results in changes in growth under glutamine‐replete conditions. In glutamine‐limiting medium, compared to control cells passaged in glutamine‐rich medium, the selected cells showed higher glutamine synthetase (GS) activity and attained a higher peak viable cell density (PVCD). Surprisingly, in glutamine‐replete conditions, selected cells still showed a higher GS activity but a lower PVCD. We show that in glutamine‐replete medium, PVCD of selected cells was restored on (a) inhibition of GS activity with methionine sulfoximine, (b) supplementation of aspartate—without affecting GS activity, and (c) supplementation of serine, which is reported to inhibit GS in vitro. Consistent with the reported effect of serine, inhibition of GS activity was observed upon serine supplementation along with reduced growth of cells under glutamine‐limiting conditions. The latter observation is important for the design of glutamine‐free culture medium and feed used for GS‐CHO and GS‐NS0. In summary, we show that CHO cells selected under glutamine limitation have superfluous GS activity in glutamine‐replete medium, which negatively affects their PVCD. This may be due to its effect on availability of aspartate which was the limiting nutrient for the growth of selected cells in glutamine‐replete conditions.


  • Integrative analysis of rewired central metabolism in temozolomide resistant cells

    by Selva Rupa C. Immanuel, Avinash D. Ghanate, Dharmeshkumar S. Parmar, Fiona Marriage, Venkateswarlu Panchagnula, Philip J. Day, Anu Raghunathan


  • Open Access

    A scalable metabolite supplementation strategy against antibiotic resistant pathogen Chromobacterium violaceum induced by NAD+/NADH+ imbalance

    by Deepanwita Banerjee, Dharmeshkumar Parmar, Nivedita Bhattacharya, Avinash D. Ghanate, Venkateswarlu Panchagnula, Anu Raghunathan

    The leading edge of the global problem of antibiotic resistance necessitates novel therapeutic strategies. This study develops a novel systems biology driven approach for killing antibiotic resistant pathogens using benign metabolites. Controlled laboratory evolutions established chloramphenicol and streptomycin resistant pathogens of Chromobacterium. These resistant pathogens showed higher growth rates and required higher lethal doses of antibiotic. Growth and viability testing identified malate, maleate, succinate, pyruvate and oxoadipate as resensitising agents for antibiotic therapy. Resistant genes were catalogued through whole genome sequencing. Intracellular metabolomic profiling identified violacein as a potential biomarker for resistance. The temporal variance of metabolites captured the linearized dynamics around the steady state and correlated to growth rate. A constraints-based flux balance model of the core metabolism was used to predict the metabolic basis of antibiotic susceptibility and resistance. The model predicts electron imbalance and skewed NAD/NADH ratios as a result of antibiotics – chloramphenicol and streptomycin. The resistant pathogen rewired its metabolic networks to compensate for disruption of redox homeostasis. We foresee the utility of such scalable workflows in identifying metabolites for clinical isolates as inevitable solutions to mitigate antibiotic resistance.


  • CHO Cells adapted to inorganic phosphate limitation show higher growth and higher pyruvate carboxylase flux in phosphate replete conditions

    by Vishwanathgouda Maralingannavar, Dharmeshkumar Parmar, Tejal Pant, Chetan Gadgil, Venkateswarlu Panchagnula, Mugdha Gadgil

    Inorganic phosphate (Pi) is an essential ion involved in diverse cellular processes including metabolism. Changes in cellular metabolism upon long term adaptation to Pi limitation have been reported in E. coli. Given the essential role of Pi, adaptation to Pi limitation may also result in metabolic changes in animal cells. In this study, we have adapted CHO cells producing recombinant IgG to limiting Pi conditions for 75 days. Not surprisingly, adapted cells showed better survival under Pi limitation. Here, we report the finding that such cells also showed better growth characteristics compared to control in batch culture replete with Pi (higher peak density and integral viable cell density), accompanied by a lower specific oxygen uptake rate and cytochrome oxidase activity towards the end of exponential phase. Surprisingly, the adapted cells grew to a lower peak density under glucose limitation. This suggests long term Pi limitation may lead to selection for an altered metabolism with higher dependence on glucose availability for biomass assimilation compared to control. Steady state U‐13C glucose labeling experiments suggest that adapted cells have a higher pyruvate carboxylase flux. Consistent with this observation, supplementation with aspartate abolished the peak density difference whereas supplementation with serine did not abolish the difference. This supports the hypothesis that cell growth in the adapted culture might be higher due to a higher pyruvate carboxylase flux. Decreased fitness under carbon limitation and mutations in the sucABCD operon has been previously reported in E. coli upon long term adaptation to Pi limitation, suggestive of a similarity in cellular response among such diverse species. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:749–758, 2017


  • Matrix-assisted laser desorption/ionization mass spectrometry analysis of dimethyl arginine isomers from urine

    by Nivedita Bhattacharya, Ajeet Singh, Avinash Ghanate, Gayatri Phadke, Dharmesh Parmar, Deepika Dhaware, Trayambak Basak, Shantanu Sengupta, Venkateswarlu Panchagnula

    Isomeric asymmetric and symmetric dimethyl arginine (ADMA and SDMA respectively) residues are excreted in urine and are putative markers of cardiovascular and chronic kidney diseases. In this work, we demonstrate simultaneous and quantitative detection of endogeneous ADMA and SDMA from urine samples of healthy subjects using MALDI-TOF MS without any chromatographic separation. The DMA isomers yielded [M + H]+ ions along with their product ions formed due to MALDI in-source fragmentation. The precursor ions were validated using MALDI-TOF MS/MS as well as direct injection ESI-Q-TOF MS/MS. ADMA and SDMA generated unique product ions at ∼ m/z 46 and ∼ m/z 172 respectively in the MS-mode itself. These were advantageously used for full scan-mode absolute quantification of the isomeric metabolites. The m/z observed for all the ions was within 10 ppm mass accuracy. The calibration method was established by generating internal standard normalized peak area-based concentration response curves using synthetic standards. Good linearities (R2 > 0.95) with acceptable intra-assay, inter-assay variation (within 15% RSD) and excellent recoveries were observed for quality control samples. Finally, endogeneous concentrations of the metabolites were determined in urine from healthy subjects (n = 11). ADMA and SDMA were found to be in the range of 1.6–8 μM and 2.9–9.1 μM in urine and were in agreement with previously reported physiological levels.